NCT03965949

Different Strategies in Frozen IVF/ICSI Cycles

Impact of Different Strategies in Frozen Cycles Using HRT in Normo Responding Patients Undergoing IVF/ICSI Cycles: a Multicenter Cohort Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 311 (actual)
• Sponsor: National and Kapodistrian University of Athens · Academic / Other
• Sex: Female
• Age: 25 Years – 42 Years
• Healthy volunteers: Accepted

Summary

In the absence of robust contemporary data, investigators decided to perform a multicenter cohort study of various IVF centers, to compare the different modalities used for pregnancy rates following frozen-thawed embryo transfer (FET) treatment cycles in normoovulatory patients undergoing IVF/ICSI.

Detailed description

In general, the type of FET protocol for each patient is selected by the attending physicians at their own discretion. In all centers, patients with ovulatory cycles are typically prescribed an NC-FET or mNC-FET, whereas patients with oligomenorrhoea or amenorrhoea are prescribed an artificial cycle to prepare the endometrium for FET. Ovarian stimulation protocol 1. The antagonist protocol 2. The long 21 /2 agonist protocol Laboratory technique a. IVF or b. ICSI Embryo freezing using only vitrification will be performed in days 3 or 5/6. Embryo transfer will be conducted at days 3 or 5/6. The maximum number of embryos transferred will be two, as in accordance to the Hellenic legislation. The following modalities will be analyzed, patients with: 1. Natural cycle, spontaneous ovulation or ovulation triggering by exogenous hCG without luteal support (Group 1) 2. Natural cycle, spontaneous ovulation or ovulation triggering by exogenous hCG with luteal support (progesterone) (Group 2) 3. Hormone Replacement cycle (cyclacur) plus GnRHa suppression with luteal support (progesterone) (Group 3) 4. Hormone Replacement cycle (cyclacur) without GnRHa suppression with luteal support (progesterone) (Group 4) Of note, the conversion between different supplementation methods may be testimated as follows: 0.75 mg of micronised estradiol (oral administration) = 1.25 g of estradiol gel (transdermal administration) = 1 mg of estradiol valerate (oral or vaginal adminstration).

Conditions

• Pregnancy Rates

Interventions

Type	Name	Description
DRUG	Hormone Replacement cycle 1	Hormone Replacement cycle (cyclacur) without GnRHa suppression with luteal support (progesterone)
DRUG	Hormone Replacement cycle 2	Hormone Replacement cycle with GnRHa suppression

Timeline

• Start date: 2019-06-06
• Primary completion: 2019-12-02
• Completion: 2019-12-02
• First posted: 2019-05-29
• Last updated: 2020-09-09

Locations

1 site across 1 country: Greece